XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF WARRANT OUTSTANDING (Details)
shares in Thousands
 6 Months Ended
Jun. 30, 2023
$ / shares
shares
Consultants For Services [Member]  
Grants of warrants 2,138 [1]
Number of stock options, options outstanding, exercised, shares (4,667) [2]
Number of stock options, options outstanding, forfeited, shares (10)
Private Placement [Member]  
Grants of warrants 11,333 [3]
Warrant [Member]  
Warrants outstanding, beginning balance 3,616
Warrant price, beginning balance | $ / shares $ 5.80 [4]
Weighted average remaining contractual life, beginning 2 years 6 months [5]
Warrants outstanding, beginning balance 12,410 [6]
Warrant price, beginning balance | $ / shares $ 2.40 [4]
Weighted average remaining contractual life, beginning 6 years [5]
Warrants outstanding, exercisable ending balance 10,638 [7]
Warrant price, exercisable ending balance | $ / shares $ 2.51 [4]
Weighted average remaining contractual life, exercisable ending 4 years 2 months 12 days [5]
[1] In February 2023, the Company granted warrants to consultants in exchange for business development, product development and distribution. Warrants issued in February 2023 provide for the purchase of an aggregate of 2,100,000 shares of common stock at an exercise price of $0.91 and $0.61 per share with a fair value of approximately $1.3 million which will be recognized upon the achievement of performance metrics and milestones. In June 2023, the Company granted warrants to consultants in exchange for services. Warrants issued in June 2023 provide for the purchase of an aggregate of 37,500 shares of common stock at an exercise price of $0.41 per share at a fair value of approximately $0.1 million which will be recognized upon the achievement of performance metrics and milestones. For the six months ended June 30, 2023, the Company recognized expense of $0.8 million.
[2] In March 2023, the Company issued an aggregate of 4,666,667 shares of common stock from the exercise of warrants previously issued in January 2023.
[3] In January 2023, the Company granted warrants in connection with a private placement consisting of pre-funded warrants to purchase up to an aggregate of 4,666,667 shares of common stock at an exercise price of $0.0001 per share, and warrants to purchase up to an aggregate of 6,666,667 shares of common stock at an exercise price of $1.20 per share with a fair value of approximately $14.5 million which was recognized as warrant liability at the time of issuance.
[4] Represents the weighted average exercise price.
[5] Represents the weighted average remaining contractual term until the warrants expire.
[6] As of June 30, 2023, the aggregate intrinsic value of warrants outstanding was $0.
[7] As of June 30, 2023, the aggregate intrinsic value of warrants exercisable was $0.25 million.